7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Goater JJ et al. | Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis. | 2002 | J. Orthop. Res. | pmid:11918293 |
Roux S et al. | RANK (receptor activator of nuclear factor-kappaB) and RANKL expression in multiple myeloma. | 2002 | Br. J. Haematol. | pmid:11918537 |
Oshiro T et al. | Osteoclast induction in periodontal tissue during experimental movement of incisors in osteoprotegerin-deficient mice. | 2002 | Anat. Rec. | pmid:11920384 |
Redlich K et al. | Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin. | 2002 | Arthritis Rheum. | pmid:11920416 |
Khosla S et al. | Effect of estrogen versus testosterone on circulating osteoprotegerin and other cytokine levels in normal elderly men. | 2002 | J. Clin. Endocrinol. Metab. | pmid:11932280 |
Kanematsu M et al. | Vector-averaged gravity regulates gene expression of receptor activator of NF-kappaB (RANK) ligand and osteoprotegerin in bone marrow stromal cells via cyclic AMP/protein kinase A pathway. | 2002 | Bone | pmid:11934645 |
Li X et al. | Effects of prostaglandin E2 on gene expression in primary osteoblastic cells from prostaglandin receptor knockout mice. | 2002 | Bone | pmid:11934647 |
Jain RG and Lenhard JM | Select HIV protease inhibitors alter bone and fat metabolism ex vivo. | 2002 | J. Biol. Chem. | pmid:11937496 |
Schoppet M et al. | RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function. | 2002 | Arterioscler. Thromb. Vasc. Biol. | pmid:11950689 |
Ariyasu T et al. | Trehalose augments osteoprotegerin production in the FHs74Int human intestinal epithelial cell line. | 2002 | In Vitro Cell. Dev. Biol. Anim. | pmid:11963965 |
Bateman TA and Countryman S | Osteoprotegerin and bone loss associated with spaceflight. | 2002 | Drug Discov. Today | pmid:11965392 |
Inoue D and Matsumoto T | [Recent advances in basic research of bone metabolism]. | 2002 | Nippon Rinsho | pmid:11979916 |
Suzuki Y et al. | [Bone destruction and bone loss in rheumatoid arthritis--mechanism, prevention and treatment]. | 2002 | Nippon Rinsho | pmid:11979937 |
Inoue D | [Recent advances in research of bone resorption]. | 2002 | Nippon Rinsho | pmid:11979946 |
Udagawa N and Takahashi N | [Possible role of receptor activator of NF-kappa B ligand(RANKL) in osteoclast differentiation and function]. | 2002 | Nippon Rinsho | pmid:11979968 |
Tsuda E | [Osteoclastogenesis inhibitory factor (OCIF)/OPG (a novel therapeutic candidate for the treatment of metabolic bone diseases)]. | 2002 | Nippon Rinsho | pmid:11979969 |
Koshihara Y | [Recent progress of bone cell culture system (review)]. | 2002 | Nippon Rinsho | pmid:11979973 |
Hasegawa T et al. | Human periodontal ligament cells derived from deciduous teeth induce osteoclastogenesis in vitro. | 2002 | Tissue Cell | pmid:11989970 |
Evdokiou A et al. | Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis. | 2002 | Int. J. Cancer | pmid:11992538 |
Corey E et al. | Establishment and characterization of osseous prostate cancer models: intra-tibial injection of human prostate cancer cells. | 2002 | Prostate | pmid:11992617 |